Anne-Els van de Logt Selected Research

Membranous Glomerulonephritis (Membranous Nephropathy)

3/2023	Antibody-Guided Therapy in Phospholipase A2 Receptor-Associated Membranous Nephropathy.
7/2021	Corrigendum to Berchtold L, Letouzé E, Alexander MP, et al. HLA-D and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipients. Kidney Int. 2021;99:671-685.
6/2021	Anti-PLA2R1 Antibodies as Prognostic Biomarker in Membranous Nephropathy.
1/2021	The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy.
1/2021	HLA-D and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anne-Els van de Logt Research Topics

Disease

5	Membranous Glomerulonephritis (Membranous Nephropathy) 03/2023 - 01/2021
1	Proteinuria 06/2021
1	Disease Progression 06/2021
1	Disease Susceptibility (Diathesis) 01/2021
1	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2021

Drug/Important Bio-Agent (IBA)

2	Phospholipase A2 ReceptorsIBA 03/2023 - 06/2021
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2023 - 01/2021
2	HLA-D AntigensIBA 07/2021 - 01/2021
1	SteroidsIBA 03/2023
1	AntibodiesIBA 06/2021
1	CreatinineIBA 06/2021
1	Biomarkers (Surrogate Marker)IBA 06/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2021
1	Rituximab (Mabthera)FDA Link 01/2021

Therapy/Procedure

1	Therapeutics 03/2023
1	Transplantation 01/2021